Delivery Order SPE2DB24D2010-SPE2DB24FZVS9

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,051.40 firm-fixed-price delivery order is for the supply of 40,000-unit capsules of the drug Zenpep. The contract has an ultimate completion date of April 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,141.71 firm fixed-price delivery order covers the procurement of 4,564,544,240 units of the drug ZENPEP DR 20,000 in 100-count capsule containers. The contract has a completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award is a delivery order valued at $11,787.39 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a medical product, with a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) is a Firm Fixed Price Delivery Order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,697.70 contract is for the supply of 40,000-unit capsules of the drug ZENPEP DR, with an ultimate completion date of November 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,364.06, is a delivery order for the supply of 40,000 units of the drug ZENPEP in 100-count capsule bottles. The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order worth $31,927.34 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 60,000 unit capsules of the drug ZENPEP DR 100S, which is used for various medical conditions. The contract is a firm fixed-price agreement with a completion date of February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 20,000 unit capsules of the drug ZENPEP DR 100S. The $2,972.08 firm fixed-price contract has a completion date of February 20, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,267.00 fixed-price delivery order is for the supply of 4564286748 - ZENPEP DR 25,000 UNIT CAPSULE 100S, with a completion date of April 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of pharmaceutical products and medical supplies. The contract has a ceiling value of $14,631.85 and is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $26,525.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,568,121,173 units of the medication ZENPEP DR 60,000 in 100-count capsule bottles. The contract has a firm fixed price pricing type and an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZVS9
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 15,000-unit capsules of the drug Zenpep. The firm-fixed-price contract has a ceiling value of $11,949 and an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order contract is not designated with a set-aside requirement, indicating open competition.

Generated 5/17/25, 10:11 AM